Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Mar;85(3):899-903.
doi: 10.1172/JCI114517.

In vitro autoantibody production by normal adult and cord blood B cells

Affiliations

In vitro autoantibody production by normal adult and cord blood B cells

D S Pisetsky et al. J Clin Invest. 1990 Mar.

Abstract

To investigate the repertoire of autoantibodies in humans, anti-DNA and rheumatoid factor (RF) production in vitro was assessed in cultures of adult peripheral blood B cells and neonatal umbilical venous blood B cells. B cells were stimulated under various culture conditions, using an immobilized monoclonal anti-CD3 antibody and adult T cells or Staphylococcus aureus (SA) in the presence or absence of adult T cells or factors derived from mitogen-stimulated adult T cells as polyclonal B cell activators. Total IgM, as well as IgM anti-DNA and RF, were assessed by ELISA. Total IgM production was induced from adult and neonatal B cells with SA plus T cell factors, as well as anti-CD3-stimulated T cells. RF was induced from adult and cord blood B cells by either mode of stimulation, whereas significant anti-DNA production was observed only when B cells were stimulated with anti-CD3-activated T cells. These results confirm the presence of B cell precursors for autoantibodies in the preimmune as well as normal adult repertoire, and indicate that the production of anti-DNA and RF appears to be regulated independently.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1977 Oct;119(4):1213-7 - PubMed
    1. J Immunol. 1988 Dec 15;141(12):4165-72 - PubMed
    1. J Clin Invest. 1980 Aug;66(2):383-8 - PubMed
    1. J Immunol. 1981 Mar;126(3):910-4 - PubMed
    1. J Immunol. 1981 Oct;127(4):1314-7 - PubMed

Publication types